Trademarkia Logo

Canada

C$
Plus Cross Design
SEARCHED

on 15 Jan 2025

Last Applicant/ Owned by

Enveric Biosciences, Inc.

4851 Tamiami Trail NSuite 200Naples, FL 34103

US

Serial Number

2203923 filed on 12th Aug 2022

Correspondent Address

PIASETZKI NENNIGER KVAS LLP

SUITE 2308120 ADELAIDE STREET WESTTORONTO

ONTARIO

CA

M5H1T1

Plus Cross Design

Trademark usage description

pharmaceutical products and preparations for the treatment of medical conditions and disorders; pharmaceutical substances for use in the prevention, t Read More

Vienna Information


24 . 13 . 1

Greek cross, St. Andrew's crossCroix grecque ou de Saint-André

24 . 13 . 25

Other crossesAutres croix

24 . 13 . 26

Incomplete crossesCroix incomplètes

24 . 17 . 5

Mathematical signsSignes mathématiques

24 . 17 . 7

Mathematical signs combined with figures or lettersSignes mathématiques combinés avec des chiffres ou des lettres

26 . 3 . 23

Lines or bands forming an angle -- Note: Including chevrons and arrowheads formed by lines or bands.Lignes ou bandes formant un angle -- Note: Y compris les chevrons et les pointes de flèches formées par des lignes ou des bandes.

25 . 12 . 3

Moiré surfaces or backgroundsSurfaces ou fonds moirés

Classification Information


Class [005]
Pharmaceutical products and preparations for the treatment of medical conditions and disorders; pharmaceutical substances for use in the prevention, treatment and management of cancer, pain, mental health disorders, cancer related distress, anxiety, depression and post-traumatic stress disorder; pharmaceutical substances for use in the management of side effects from chemotherapy, radiation therapy, immunotherapy, and cancer treatment; anti-cancer preparations; pharmaceutical products for the treatment of cancer.


Classification kind code

11

Class [042]
Pharmaceutical research services; medical research services; medical research laboratory services; research and development of new products for others; research and development services, for the development of a portfolio of psychoactive compounds and derivatives targeted for the treatment of medical conditions and disorders; research and development services, for the development of a portfolio of compounds and derivatives targeted for the treatment of cancer and the side effects of cancer; providing online non-downloadable computer software for data analytics, machine learning, knowledge management, and predictive analysis of biostatistical data and treatment data, in the field of medical research; scientific and technological research services in the fields of medicine, biotechnology, and pharmaceuticals; scientific and technological research and drug development in the fields of cancer, pain, mental health disorders, cancer related distress, anxiety, depression and post-traumatic stress disorder; product development of pharmaceutical substances and medicines; pharmaceutical and medical research and development; pharmaceutical testing services; scientific laboratory services; research laboratory services relating to pharmaceuticals.


Classification kind code

11

Mark Details


Serial Number

2203923

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 22
on 15th Jan 2025
Search Recorded
Submitted for opposition 20
on 15th Jan 2025
Examiner's First Report
Submitted for opposition 287
on 18th Aug 2022
Pre-Assessment Letter Sent
Submitted for opposition 30
on 12th Aug 2022
Filed
Submitted for opposition 1
on 12th Aug 2022
Created
Submitted for opposition 31
on 12th Aug 2022
Formalized